The FTC’s five Commissioners issue statements on a range of important topics to engage with the public and express the views of the Commission as well as their own individual views.
Displaying 541 - 560 of 1034
Statement of Commissioner Rohit Chopra Regarding the Request for Comment on Vertical Merger Guidelines
Date
By
Rohit Chopra, Former Commissioner
Matter Number
P810034
Concurring Statement of Commissioner Christine S. Wilson Concerning the Publication of FTC-DOJ Draft Vertical Merger Guidelines for Public Comment
Date
By
Christine S. Wilson, Former Commissioner
Matter Number
P810034
Statement of Rebecca Kelly Slaughter on the FTC-DOJ Draft Vertical Merger Guidelines
Date
By
Rebecca Kelly Slaughter, Former Commissioner
Matter Number
P810034
Statement of the Federal Trade Commission in the matter of Roche Holding/Spark Therapeutics
Date
By
Joseph J. Simons, Former Chairman;
Noah Joshua Phillips, Former Commissioner;
Rohit Chopra, Former Commissioner;
Rebecca Kelly Slaughter, Former Commissioner;
Christine S. Wilson, Former Commissioner
Matter Number
191 0086
Statement of Commissioner Rohit Chopra In the Matter of the University of Phoenix, Inc.
Date
By
Rohit Chopra, Former Commissioner
Matter Number
152 3231
Concurring Statement of Commissioner Rebecca Kelly Slaughter In the Matter of the University of Phoenix, Inc.
Date
By
Rebecca Kelly Slaughter, Former Commissioner
Matter Number
152 3231
Statement of Commissioner Noah Joshua Phillips In the Matter of Bristol-Myers Squibb Company and Celgene Corporation
Date
By
Noah Joshua Phillips, Former Commissioner
Matter Number
191 0061
Docket Number
C-4690
Dissenting Statement of Commissioner Rohit Chopra In the Matter of Bristol-Myers Squibb Company and Celgene Corporation
Date
By
Rohit Chopra, Former Commissioner
Matter Number
191 0061
Docket Number
C-4690
Statement of Commissioner Christine S. Wilson In the Matter of Bristol-Myers Squibb Company and Celgene Corporation
Date
By
Christine S. Wilson, Former Commissioner
Matter Number
191 0061
Docket Number
C-4690
File
Dissenting Statement of Commissioner Rebecca Kelly Slaughter In the Matter of Bristol-Myers Squibb Company and Celgene Corporation
Date
By
Rebecca Kelly Slaughter, Former Commissioner
Matter Number
191 0061
Docket Number
C-4690
Concurring Statement of Commissioner Christine S. Wilson In the Matter of InfoTrax Systems, L.C.
Date
By
Christine S. Wilson, Former Commissioner
Matter Number
162 3130
Statement of Federal Trade Commission In the Matter of Your Therapy Source, Neeraj Jindal and Sheri Yarbray
Date
By
Joseph J. Simons, Former Chairman;
Noah Joshua Phillips, Former Commissioner;
Rebecca Kelly Slaughter, Former Commissioner
Displaying 541 - 560 of 1034